Dr. @alegronchi on the new #Desmoid #Tumor #Consensus: ✅ 30% Require Treatment ✅ Treatment Tailored: Based on sex, age, symptoms, site, sporadic vs FAP, etc.. ✅ Principles: Primum non nocere; second, control the disease! Challenge: which patients will benefit from treatment?

Desmoid tumors ➡️ wait and see! When action is needed, the teamwork between surgeons and #interventional #radiologists shines🌟 Are you familiar with these cutting-edge #treatments? Staying informed about these options at ISG Annual Meeting 2024! @ItaSarcomaGroup